Trials / Completed
CompletedNCT02594410
Zainidip in Renal Artery Stenosis
The Efficacy of Renal Artery Stent Combined With Standardized Medical Therapy in Patients With Atherosclerotic Renal Artery Stenosis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 149 (actual)
- Sponsor
- Lee's Pharmaceutical Limited · Industry
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy of renal artery stent combined with standardized medical therapy as treatment for renal artery stenosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | stent | patients receiving renal artery stenting for renal artery atherosclerosis |
| DRUG | Aspirine | 100mg Qd |
| DRUG | Clopidogrel | 75mg Qd |
| DRUG | Lercanidipine | 10-20mg Qd |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2014-03-01
- Completion
- 2014-05-01
- First posted
- 2015-11-03
- Last updated
- 2015-11-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02594410. Inclusion in this directory is not an endorsement.